PMCB
PharmaCyte BiotechยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PMCB Profile
Pharmacyte Biotech, Inc.
A clinical-stage biotech company that developing therapies for cancer and diabetes
3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV 89169
--
PharmaCyte Biotech, Inc., is a Nevada company founded in 1996. The Company is a biotechnology company focused on developing and preparing to commercialize cell therapies for cancer, diabetes and malignant ascites based on proprietary cellulose-based living cell encapsulation technology, referred to as Cell-in-a-Box. The company is working to advance clinical research and development of new cell-based therapies for oncology and diabetes. The group has been working to complete the list of items required by the FDA. The company is also developing a method to delay the production and accumulation of malignant ascites caused by various types of abdominal cancerous tumors. The company's treatment for malignant ascites involves using the same envelope cells used for pancreatic cancer, but placing the envelope cells in the patient's abdominal cavity and injecting ifosfamide intravenously. In addition to these cancer projects, the company is also considering how to use the benefits of Cell-in-a-Box technology to develop cancer therapies, including precursors based on certain components of the cannabis plant.
